COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders- updated guideline (NG167)
Recommendation 3.2 has been updated to highlight the possible risk of adrenal crisis for patients on long-term corticosteroids.
Source:
National Institute for Health and Care Excellence